Where does Samplix APS rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Samplix APS ranks #27,300 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Samplix APS hold?

Samplix APS holds 10 US utility patents granted between 2019 and 2024, spanning 4 technology areas.

What is Samplix APS's Innovation Score?

Samplix APS has an Innovation Score of 35.8 out of 100 (top 48% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Samplix APS's patent grant rate increasing or decreasing?

Samplix APS's recent grant velocity is +800% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Samplix APS's patents?

Samplix APS's patents average 17.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Samplix APS patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Samplix APS

Q: What technology areas does Samplix APS focus on?

Samplix APS's top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 6 patents, ranking #717 of 2,502 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

USPTO PatentsView assignee record - 10 granted patents across 4 technology areas, recorded in grant years 2019–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Samplix ranks #27,300 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 4 technology areas.

#27,300
of 49,997 US assignees by volume: Top 48%
by Innovation Score (35.8/100): 17.4
avg claims per patent: +800%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R27300 · Foreign Corporation #27,300 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #27,300/49,997
PHOTO-FINISH Sabre Intellectual…
CPC-NARROW C12Q · 4 areas
INNOV-THIN 35.8/100
CLAIMS-RICH 17.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +800% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Sabre Intellectual Property Holdings LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Samplix’s 35.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.3 pts (23%) Velocity 10.0 pts (28%) Breadth 7.1 pts (20%) Claim depth 10.4 pts (29%)

Qualcomm Incorporated · highest

85
Hyperion Materials… · near

36
Cognitive Scale · near

36
Rea deeming Beauty · near

36
Samplix APS · this assignee

36
Plano Molding · near

36
3D Lighting… · lowest

7

What this shows Samplix's Innovation Score is 35.8/100 (top 48% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Samplix?

Each dot is one of Samplix’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Samplix’s own 17.4 claims/patent is ABOVE the 13.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Samplix vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Samplix's grants concentrate

Samplix APS is a focused PatentsView assignee: 4 CPC subclasses with 60% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2023 (3 grants) versus a trough of 1 in 2019. By volume, Samplix sits between Sabre Intellectual Property Holdings LLC and Sasol Technology (PTY.) Limited.

Samplix's three-year grant acceleration

Samplix APS shows 6 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Sabre Intellectua…

10
Safe Marine Trans…

10
Sage Science

10
Samp S P A CON Un…

10
Sanexen Environme…

10
Sangenic Internat…

10
Sanovo Technology…

10
Sasol Technology…

10
Samplix APS ◀

10

What this shows Samplix holds 10 patents at rank #27,290, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Samplix

By rank, the assignees closest to #27,290 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Samplix's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Samplix, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), Samplix ranks #717 of 2,502 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (36 here).

Rea.deeming Beauty, Inc. 36 Cognitive Scale, Inc. 36 Hyperion Materials & Technologies (SWEDEN) AB 36 Plano Molding Company, LLC 36

Samplix's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 48% higher than 52% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Samplix APS patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	1	10.0%
2020	2	20.0%
2021	1	10.0%
2022	1	10.0%
2023	3	30.0%
2024	2	20.0%

Which technologies does Samplix APS patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 6

B01F - Mixing, e.g. Dissolving, Emulsifying OR Dispersing 4

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 4

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 2

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Samplix APS's patent record in context - here's where to go next.

Samplix APS's lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 60% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #27,300 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Samplix APS against Sabre Intellectual Property Holdings LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.